BE849811A - Compositions pharmaceutiques pulverulentes pour le traitement de dermatomycoses pedis et leur procede de preparation. - Google Patents

Compositions pharmaceutiques pulverulentes pour le traitement de dermatomycoses pedis et leur procede de preparation.

Info

Publication number
BE849811A
BE849811A BE173598A BE173598A BE849811A BE 849811 A BE849811 A BE 849811A BE 173598 A BE173598 A BE 173598A BE 173598 A BE173598 A BE 173598A BE 849811 A BE849811 A BE 849811A
Authority
BE
Belgium
Prior art keywords
montmorillonite
weight
emi
treatment
papaya
Prior art date
Application number
BE173598A
Other languages
English (en)
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE849811A publication Critical patent/BE849811A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/26—Aluminium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01017—Lysozyme (3.2.1.17)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/22—Cysteine endopeptidases (3.4.22)
    • C12Y304/22002—Papain (3.4.22.2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BE173598A 1976-01-02 1976-12-23 Compositions pharmaceutiques pulverulentes pour le traitement de dermatomycoses pedis et leur procede de preparation. BE849811A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP15176A JPS5283903A (en) 1976-01-02 1976-01-02 Medicine for remedy of dermatophytosis

Publications (1)

Publication Number Publication Date
BE849811A true BE849811A (fr) 1977-04-15

Family

ID=11466028

Family Applications (1)

Application Number Title Priority Date Filing Date
BE173598A BE849811A (fr) 1976-01-02 1976-12-23 Compositions pharmaceutiques pulverulentes pour le traitement de dermatomycoses pedis et leur procede de preparation.

Country Status (2)

Country Link
JP (1) JPS5283903A (ja)
BE (1) BE849811A (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61225126A (ja) * 1985-02-19 1986-10-06 チャールズ　アレン　ジャンセン 無機鉱物化合物からなる医薬組成物

Also Published As

Publication number Publication date
JPS613768B2 (ja) 1986-02-04
JPS5283903A (en) 1977-07-13

Similar Documents

Publication Publication Date Title
CA1125172A (fr) Composition medicamenteuse et procede de preparation
Wang et al. Extraction, purification, bioactivity and pharmacological effects of capsaicin: a review
El-Bahr Curcumin regulates gene expression of insulin like growth factor, B-cell CLL/lymphoma 2 and antioxidant enzymes in streptozotocin induced diabetic rats
FR2646777A1 (fr) Procede de preparation d'un produit particulaire antimicrobien, produit antimicrobien obtenu et applications
CH692903A5 (fr) Biostimulant.
CA2513616A1 (fr) Composition pour une administration par voie orale contenant des capsaicinoides
FR3080989A1 (fr) Composition liquide comprenant un extrait de feuilles de cassis et du jus de pomme concentre
CH699182B1 (fr) Mélanges de miel d'abeilles pour le traitement dermatologique des plaies chroniques.
BE849811A (fr) Compositions pharmaceutiques pulverulentes pour le traitement de dermatomycoses pedis et leur procede de preparation.
EP1902631A2 (fr) Additif antioxydant naturel d'origine végétale destiné à la nutrition animale
US4108984A (en) Compositions and methods for the treatment of athlete's foot
KR101478196B1 (ko) 꾸지뽕을 주성분으로 하는 항산화 및 당뇨병 예방용 조성물
El-Bahr et al. Hepatic gene expression of insulin like growth factor and selected antioxidants in diabetic rats treated with turmeric or black cumin seed
EP3242674B1 (fr) Compositions contenant de la curcumine à biodisponibilité améliorée
BE1021928B1 (fr) Composition a base d'huile de krill et d'extrait de curcuma
EP3600370B1 (fr) Utilisation de l'oleoresine de copaifera dans les pathologies de la prostate
WO2021234165A1 (fr) Hydrolysat de protéines du tourteau des graines de moringa peregrina pour son application en tant que médicament, son procédé d'obtention et compositions pharmaceutiques et dermatologiques
WO2022090561A1 (fr) Composition naturelle pour traitement gastrique, notamment pour le traitement d'ulcères gastriques, procédé de fabrication associé et application aux équidés
EP2646501B1 (fr) Films naturels biodegradables a base de co-produits issus de processus industriels de traitement de graines
Ibrahem et al. Effect of modified ketogenic diets on rats with induced obesity
WO2006136713A2 (fr) Composition pour le traitement de la dermite estivale
WO2019080983A1 (fr) Nouvelle formulation a base de chitosane et son procede de preparation.
KR101314917B1 (ko) 숙취해소용 기능성 면의 제조방법
US4296098A (en) Compositions and methods for the treatment of athlete's foot
WO2024100153A1 (fr) Composition pour son utilisation dans le traitement d'un syndrome de l'intestin irritable et/ou dans le traitement d'une hyperpermeabilite intestinale

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: SATO MASATARO

Effective date: 19921231